放疗后临床N0颈部隐匿性淋巴结转移风险的Meta分析
结果显示总体隐匿性转移率为15.4%,不同亚部位间存在差异,局部晚期肿瘤隐匿性转移的相对风险显著更高。作者建议根据亚部位、T分期和既往淋巴结转移史考虑择区性颈清扫。
要点
- 放疗后临床N0颈部挽救性手术时总体隐匿性淋巴结转移率为15.4%。
- 不同亚部位隐匿性转移率不同:口腔16.2%、口咽12.9%、下咽23.7%、声门上/经声门27.3%。
- 局部晚期肿瘤隐匿性转移的相对风险显著更高,应考虑择区性颈清扫。
核心结论
- 放疗后临床N0颈部在挽救性手术时存在不可忽视的隐匿性淋巴结转移风险。
- 是否行择区性颈清扫应基于肿瘤亚部位、T分期和既往淋巴结转移史综合决定。
研究设计与样本
- 遵循PRISMA指南的系统综述与Meta分析。
主要发现
- 总体隐匿性转移率为15.4%。
- 合并隐匿性淋巴结转移率:口腔16.2%,口咽12.9%,下咽23.7%,声门上或经声门肿瘤27.3%。
- 局部晚期肿瘤隐匿性转移的相对风险显著更高。
关键数值与推荐
- 纳入标准:头颈部鳞状细胞癌、既往颈部淋巴结引流区放疗、因局部复发/持续或第二原发行挽救性手术、挽救时临床N0。
- 总体隐匿性转移率15.4%;口腔16.2%、口咽12.9%、下咽23.7%、声门上或经声门27.3%。
临床怎么用
- 放疗后临床N0颈部行挽救性手术时,应结合亚部位、T分期和既往淋巴结转移史评估隐匿性转移风险。
- 对高风险亚部位(如下咽、声门上/经声门)或局部晚期肿瘤,可考虑同期择区性颈清扫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recurrent head and neck squamous cell carcinoma (HNSCC) after radiation is associated with poor survival, and management of the clinically negative (N0) neck during salvage surgery is controversial. METHODS: Studies were selected according to preferred reporting items for systematic reviews and meta-analyses guidelines. Inclusion criteria were patients with HNSCC, prior radiation to the lateral neck nodal basin, undergoing salvage surgery for local recurrence, persistence or second primary, and N0 at time of salvage. Eleven studies with a total of 382 patients met inclusion criteria. RESULTS: The rate of occult metastasis was 15.4%. The pooled rate of occult nodal metastasis was 16.2% for oral cavity, 12.9% for oropharynx, 23.7% for hypopharynx, and 27.3% for supraglottic or transglottic tumors. There was a significantly higher relative risk of occult metastasis for locally advanced tumors. CONCLUSION: Elective neck dissection at time of salvage surgery should be considered based on subsite, T classification, and prior history of nodal metastasis.
引用
- Finegersh A, Moss WJ, Saddawi-Konefka R, et al. Meta-analysis of risk of occult lymph node metastasis in the irradiated, clinically N0 neck. Head Neck. 2020. PMID: 32432819. doi:10.1002/hed.26248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。